InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space
Feb 1, 2022
- Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits
- InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids
- As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market
- The company plans to launch new rare cannabinoid products in the first half of 2022
The human body naturally produces cannabinoids – endocannabinoids such as anandamide (“ANA”) – as part of a physiologic system that maintains human health by reducing inflammation and promoting homeostasis (https://cnw.fm/TPyZy). So named after the plant that led to its discovery, the endocannabinoid system (“ECS”) however only produces two known cannabinoid compounds, while over 140 variants can be found in the cannabis plant, most in trace amounts.
Of the latter group of cannabinoids, cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) are the most common. Researchers have in fact studied both…
NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.
More News
‘Cats Love Gravy’: How a Reporter Ended Up at a Pet Food Research Center
A Times journalist and animal lover spent a day at a Royal Canin facility to understand how pet food giants are studying the taste buds of dogs and cats.
Lights will stay on this winter, grid operator says after concerns
The assurance from the National Energy System Operator comes amid concern from its engineers about their ability to ensure adequate supply.
Renting in London - 'I pay £2,000 for one bedroom'
We ask people in the capital how much they pay for their homes.
'I live in the dark': How rising bills are shaping daily life
Errol McGuiness says he has changed his daily routine to cope with higher household bills.
'I'm 96 and have 15 million followers': The grannies taking over TikTok
Grandma Droniak, Nonna Gracie, Viv Truran and Barbara Costello have all found fame on social media in their later years.
L'Oreal says weight loss drugs are impacting beauty and skincare sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
What Is PHP? Why Are Government and Business Websites Going Offline?
A critical security flaw in the programming language underpinning much of the web has prompted a global rush to patch vulnerable systems.
Monet Painting Sells for $56 Million in France
The artwork, titled “Iris,” is among the painter’s later works, which wealthy collectors have coveted in recent years.
Stocks See Steepest Decline in Months Amid A.I. Worries
The S&P 500 index fell over 1.4 percent, its largest daily decline since July, while the tech-heavy Nasdaq slumped nearly 2.5 percent, that index’s biggest one-day decline since June.
Mortgage Rates Remain Above 7%, Pushing Home Prices Lower in Some Areas
The 30-year, fixed-rate mortgage dropped slightly to 7.32 percent as prospective home buyers continue to struggle with affordability. But home prices are starting to drop in some areas.
Zuckerberg wins Meta deal to help him foot bill for possible California billionaire tax
The Meta boss had said he would exit the state over a wealth tax that has not yet come into force.
A.I. and Its Dangers Are Embedded In the Midterm Elections
The midterms are the first elections in which artificial intelligence is integrated into every major social media platform. Efforts to blunt its harms are uneven.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.